Zacks Investment Research
02 Dec 2025, 15:41 UTC · 41w ago
Verdict
Headline leans bearish. We score PFE −1.00.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
Which stocks this story touches
More negative than 97% of ticker scores this week
Shares fell following FDA plans for stricter vaccine requirements and reports of vaccine-related deaths.
More negative than 97% of ticker scores this week
Shares fell following FDA plans for stricter vaccine requirements and reports of vaccine-related deaths.
Continue reading
5 related stories
More negative than 97% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 97% of ticker scores this week
Shares fell following FDA plans for stricter vaccine requirements and reports of vaccine-related deaths.
More negative than 97% of ticker scores this week
Shares fell following FDA plans for stricter vaccine requirements and reports of vaccine-related deaths.
More negative than 97% of ticker scores this week
Shares fell following FDA plans for stricter vaccine requirements and reports of vaccine-related deaths.
More positive than 57% of relationship scores this week
[mutual] Both are identified as prominent vaccine makers affected by the same FDA regulatory changes.
More positive than 57% of relationship scores this week
[mutual] Both are identified as prominent vaccine makers affected by the same FDA regulatory changes.
More positive than 57% of relationship scores this week
[mutual] Both are identified as prominent vaccine makers affected by the same FDA regulatory changes.
More positive than 57% of relationship scores this week
[mutual] Both are identified as prominent vaccine makers affected by the same FDA regulatory changes.
More positive than 57% of relationship scores this week
[mutual] Both are identified as prominent vaccine makers affected by the same FDA regulatory changes.
More positive than 57% of relationship scores this week
[mutual] Both are identified as prominent vaccine makers affected by the same FDA regulatory changes.
More positive than 57% of relationship scores this week
[mutual] Both are identified as prominent vaccine makers affected by the same FDA regulatory changes.
More positive than 57% of relationship scores this week
[mutual] Both are identified as prominent vaccine makers affected by the same FDA regulatory changes.
More positive than 57% of relationship scores this week
[mutual] Both are identified as prominent vaccine makers affected by the same FDA regulatory changes.
More positive than 57% of relationship scores this week
[mutual] Both are identified as prominent vaccine makers affected by the same FDA regulatory changes.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Reuters
3d ago
+9.2%
Price is moving against the score
$27.60 vs $25.27 close before publication (Dec 1) · not market-adjusted
PFE chart →
